![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Saxena Uday
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.16, Iss.4, 2012-04, pp. : 351-354
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cholinergic receptors and neurodegenerative diseases
By Gualtieri F.
Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chelating Agents for Neurodegenerative Diseases
Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. :